Axion BioSystems, Inc. is a life science instrumentation company that develops high-throughput microelectrode array (MEA) systems for cellular analysis, allowing researchers to recreate brain activity and heartbeats on the benchtop. As a result, drug safety, drug discovery, and disease modeling is accomplished with greater sensitivity, accuracy, and productivity.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 05/17/16 | $6,000,000 | Venture |
Georgia Research Alliance | undisclosed |
